Ferring Pharmaceuticals Announces ESHRE Data Confirming Conventional FSH Dosing for Rekovelle® Matches Follitropin Alfa in IVF

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle® (fol...

July 03, 2025 | Thursday | News
Asahi Kasei Pharma Begins Phase III Trial in Japan of ART-123 for Preventing Chemotherapy-Induced Peripheral Neuropathy

Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: thrombomodulin alfa; marketed as Recomod...

July 03, 2025 | Thursday | News
JCR Pharmaceuticals Completes Enrollment in Global Phase III Trial of JR-141 for Hunter Syndrome Across the U.S., Latin America, and Europe

-JCR Pharmaceuticals Co., Ltd. (TSE 4552; JCR) announced that it achieved the enrollment of the target number of participants in the global Phase III cli...

July 03, 2025 | Thursday | News
MaaT Pharma and Clinigen Sign Exclusive European Licensing Deal for Xervyteg® in Acute Graft-Versus-Host Disease

MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg® (MaaT013),...

July 03, 2025 | Thursday | News
Carthera’s SonoCloud® Wins EMA Endorsement as Orphan Medical Device for Recurrent Glioblastoma

Carthera, a spin-off from Sorbonne University founded by Pr. Alexandre Carpentier, and developer of SonoCloud®, an innovative ultrasound-based med...

July 02, 2025 | Wednesday | News
Alvotech and Advanz Pharma Forge Agreement to Commercialise Biosimilar Candidate to Cimzia® Across Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

July 02, 2025 | Wednesday | News
Axplora Launches €35 Million Farmabios Expansion to Reinforce API Manufacturing Leadership in Italy

Axplora is proud to unveil a transformative €35 million expansion at its Farmabios site  in Gropello Cairoli, Italy, reinforcing the company&rsqu...

July 02, 2025 | Wednesday | News
Addex Therapeutics Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine for Autism and Neuropsychiatric Disorders

Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for ...

July 01, 2025 | Tuesday | News
Valneva Partners with CSL Seqirus to Distribute Chikungunya, Japanese Encephalitis, and Cholera Vaccines in Germany

Valneva SE, , a specialty vaccine company, announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companie...

June 30, 2025 | Monday | News
Mabion and NovalGen Forge Strategic Partnership to Advance First-in-Class T-Cell Engager NVG-222 Into Clinical Trials

In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end- to-end biologics CDMO Mabion hav...

June 30, 2025 | Monday | News
MGI Tech and Negedia Join Forces to Expand Access to Spatial Transcriptomics and Precision Genomics in Italy

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a pa...

June 27, 2025 | Friday | News
Cytiva’s “In-Region, For-Region” Strategy Powers $1.6 Billion Global Biomanufacturing Expansion

Since 2019, Cytiva has committed over $1.6 billion to expand its global manufacturing capacity. In this exclusive conversation with BioPharma BoardRoom, Pi...

July 01, 2025 | Tuesday | Interview
GenSight Biologics Completes Upstream Tech Transfer of LUMEVOQ® Manufacturing to Catalent

Upstream phase of LUMEVOQ® manufacturing process successfully transferred Milestone follows successful manufacture of drug product batch to be u...

June 26, 2025 | Thursday | News
Sanofi’s Riliprubart Secures FDA Orphan Drug Status for AMR in Transplants; Phase 2 Kidney Study Underway

Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant reci...

June 25, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close